| Literature DB >> 27596361 |
Madhu Nagappa1, Parayil Sankaran Bindu2, Shwetha Chiplunkar3, Periasamy Govindaraj1, Gayathri Narayanappa4, Ayyappan Krishnan5, M M Srinivas Bharath6, Aarthi Swaminathan7, Jitender Saini7, Hanumanthapura R Arvinda7, Sanjib Sinha5, Pavagada S Mathuranath5, Arun B Taly1.
Abstract
Deficiency of gamma-amino-butyrate aminotransferase (ABAT) is a rare inherited disorder. A six-month-old girl presented with hyper-somnolence, hyperkinetic movements of distal extremities during wakefulness, hypotonia, bi-pyramidal signs, and impaired response to sound and visual stimuli. Brain MRI at five months showed restricted diffusion along the internal capsule and genu of corpus callosum. A follow up MRI at 18months, showed hyperintensities in brainstem, external and internal capsule, 'trilaminated' appearance of posterior limb of internal capsule and dysmyelination of sub-cortical white matter. MRS showed a peak between 2.2ppm and 2.4ppm, corresponding to glutamine, glutamate and GABA. EEG was normal at six months but showed multifocal epileptiform discharges at 18months. Targeted exome sequencing revealed compound heterozygous missense variations in ABAT resulting in its reduced function. We report the novel association of hypersomnolence and hyperkinetic movement disorder with ABAT variations thus expanding the clinical spectrum of this uncommon neuro-metabolic disorder and discuss the emerging role of GABA in pathways regulating sleep-wake cycle and movement disorders.Entities:
Keywords: ABAT; GABA; Hyperkinetic movement disorder; Hypersomnolence
Mesh:
Substances:
Year: 2016 PMID: 27596361 DOI: 10.1016/j.braindev.2016.08.005
Source DB: PubMed Journal: Brain Dev ISSN: 0387-7604 Impact factor: 1.961